RWD102 The Real-World Effectiveness of Tixagevimab and Cilgavimab in Immunocompromised Patients: A Single Center Study in Taiwan

Abstract

Authors

H.C. Yu C.H. Lin K.C. Chang H.Y. Chen

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×